Pulmonx Historical Financial Ratios
| LUNG Stock | USD 6.45 0.15 2.38% |
Pulmonx Corp is promptly reporting on over 102 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 64.09 will help investors to properly organize and evaluate Pulmonx Corp financial condition quickly.
Pulmonx |
About Pulmonx Financial Ratios Analysis
Pulmonx CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Pulmonx Corp investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Pulmonx financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Pulmonx Corp history.
Pulmonx Corp Financial Ratios Chart
Add Fundamental
Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Average Inventory
The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.Most ratios from Pulmonx Corp's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Pulmonx Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.At this time, Pulmonx Corp's Stock Based Compensation To Revenue is most likely to increase slightly in the upcoming years. The Pulmonx Corp's current PB Ratio is estimated to increase to 4.30, while Days Sales Outstanding is projected to decrease to 64.09.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 8.08 | 7.85 | 11.97 | 6.07 | Days Of Inventory On Hand | 464.89 | 385.29 | 340.97 | 251.91 |
Pulmonx Corp fundamentals Correlations
Click cells to compare fundamentals
Pulmonx Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pulmonx Corp fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 42.72 | 75.26 | 23.93 | 5.83 | 7.05 | 6.7 | |
| Ptb Ratio | (7.43) | 10.89 | 6.0 | 2.03 | 4.09 | 4.3 | |
| Days Sales Outstanding | 67.17 | 47.15 | 49.47 | 59.02 | 64.34 | 64.09 | |
| Book Value Per Share | (5.29) | 6.34 | 5.35 | 4.15 | 3.12 | 3.27 | |
| Free Cash Flow Yield | (0.0154) | (0.0128) | (0.0389) | (0.15) | (0.0793) | (0.0833) | |
| Operating Cash Flow Per Share | (0.59) | (0.86) | (1.15) | (1.22) | (0.99) | (1.04) | |
| Stock Based Compensation To Revenue | 0.0112 | 0.0977 | 0.22 | 0.31 | 0.32 | 0.34 | |
| Capex To Depreciation | 1.97 | 1.89 | 4.23 | 0.87 | 0.52 | 0.5 | |
| Pb Ratio | (7.43) | 10.89 | 6.0 | 2.03 | 4.09 | 4.3 | |
| Ev To Sales | 42.94 | 69.02 | 21.41 | 4.39 | 6.44 | 6.12 | |
| Roic | (0.55) | (0.13) | (0.23) | (0.33) | (0.39) | (0.41) | |
| Net Income Per Share | (0.58) | (0.9) | (1.35) | (1.59) | (1.6) | (1.68) | |
| Days Of Inventory On Hand | 201.2 | 339.99 | 464.89 | 385.29 | 340.97 | 251.91 | |
| Payables Turnover | 3.8 | 7.83 | 8.08 | 7.85 | 11.97 | 6.07 | |
| Sales General And Administrative To Revenue | 1.05 | 1.36 | 1.34 | 1.44 | 1.31 | 1.0 | |
| Capex To Revenue | 0.0221 | 0.0278 | 0.0758 | 0.0246 | 0.0118 | 0.0112 | |
| Cash Per Share | 0.8 | 6.49 | 4.98 | 3.8 | 3.08 | 2.58 | |
| Pocfratio | (67.06) | (80.42) | (28.0) | (6.94) | (12.87) | (13.52) | |
| Interest Coverage | (7.7) | (10.16) | (57.06) | (55.01) | (19.16) | (20.12) | |
| Capex To Operating Cash Flow | (0.0347) | (0.0297) | (0.0887) | (0.0292) | (0.0215) | (0.0225) | |
| Pfcf Ratio | (64.82) | (78.1) | (25.71) | (6.74) | (12.6) | (13.23) | |
| Days Payables Outstanding | 96.12 | 46.59 | 45.16 | 46.51 | 30.49 | 59.73 | |
| Ev To Operating Cash Flow | (67.4) | (73.75) | (25.05) | (5.22) | (11.75) | (12.34) | |
| Pe Ratio | (67.26) | (76.44) | (23.81) | (5.31) | (7.96) | (8.36) | |
| Return On Tangible Assets | (0.41) | (0.12) | (0.21) | (0.31) | (0.35) | (0.36) | |
| Ev To Free Cash Flow | (65.14) | (71.62) | (23.01) | (5.07) | (11.51) | (12.08) | |
| Intangibles To Total Assets | 0.0534 | 0.0104 | 0.0111 | 0.0128 | 0.0133 | 0.0126 | |
| Net Debt To E B I T D A | (0.42) | 7.19 | 2.62 | 1.38 | 0.76 | 1.29 | |
| Current Ratio | 2.9 | 19.96 | 11.85 | 9.14 | 6.5 | 6.9 | |
| Tangible Book Value Per Share | (5.37) | 6.26 | 5.28 | 4.08 | 3.05 | 3.21 | |
| Receivables Turnover | 5.43 | 7.74 | 7.38 | 6.18 | 5.67 | 5.1 | |
| Graham Number | 8.34 | 11.35 | 12.73 | 12.18 | 10.6 | 9.06 | |
| Shareholders Equity Per Share | (5.29) | 6.34 | 5.35 | 4.15 | 3.12 | 3.27 | |
| Debt To Equity | (1.18) | 0.0867 | 0.0901 | 0.16 | 0.34 | 0.36 |
Currently Active Assets on Macroaxis
When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.154 | Return On Assets (0.20) | Return On Equity (0.52) |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.